參考文献:
[1] Luo Z, Fabre G,
Rodwin VG. Meeting the Challenge of Diabetes in China. Int J Health Policy
Manag. 2020; 9:47-52.
[2] A novel insulin
receptor-binding protein from Momordica charantia enhances glucose uptake and
glucose clearance in vitro and in vivo through triggering insulin receptor
signaling pathway. J. Agric. Food Chem. 2014; 62:8952–8961.
[3]Lo HY, Ho TY, Lin C,
Li CC, Hsiang CY. Momordica charantia and its novel polypeptide regulate
glucose homeostasis in mice via binding to insulin receptor. J Agric Food Chem.
2013; 61:2461-2468
[4] Lo H.Y., Li C.C.,
Ho T.Y., Hsiang C.Y. Identification of the bioactive and consensus peptide
motif from Momordica charantia insulin receptor-binding protein. Food Chem.
2016;204:298–305.
[5] Hsu PK, Pan FFC,
Hsieh CS. mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes
Mellitus (DM) Patients’ Blood Sugar Levels. Nutrients. 2020; 12:1252.
[6] Pan F, Hsu PK,
Chang WH. Exploring the Factors Affecting Bitter Melon Peptide Intake Behavior:
A Health Belief Model Perspective. Risk Manag Healthc Policy. 2020;
13:2219-2226.
[7]
https://insumate.org/